Cost-effectiveness of a new autoantibody test added to Computed Tomography (CT) compared to CT surveillance alone in the diagnosis of lung cancer amongst patients with indeterminate pulmonary nodules

Oncimmune's EarlyCDT®-Lung is a simple ELISA blood test that measures seven lung cancer specific autoantibodies and is used in the assessment of malignancy risk in patients with indeterminate pulmonary nodules (IPNs). The objective of this study was to examine the cost-effectiveness of EarlyCDT...

Descripción completa

Detalles Bibliográficos
Autores principales: Sutton, Andrew John, Sagoo, Gurdeep S., Jackson, Leon, Fisher, Mike, Hamilton-Fairley, Geoffrey, Murray, Andrea, Hill, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467291/
https://www.ncbi.nlm.nih.gov/pubmed/32877432
http://dx.doi.org/10.1371/journal.pone.0237492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467291/
https://www.ncbi.nlm.nih.gov/pubmed/32877432
http://dx.doi.org/10.1371/journal.pone.0237492

Ejemplares similares